Quantcast
Teva Pharmaceuticals: How Safe is the High Dividend Yield? | The Mesh Report

Teva Pharmaceuticals: How Safe is the High Dividend Yield?

Dividend Sensei May 19, 2017 Comments Off on Teva Pharmaceuticals: How Safe is the High Dividend Yield?

All pharmaceuticals have been hit in recent months by concerns over healthcare reform. However, Teva Pharmaceuticals in particular has experienced a rash of bad news that has absolutely crushed the stock and sent its yield soaring to among the highest in the industry. Find out why investors shouldn’t be worried about the safety of the payout, and why this represents an excellent long-term buying opportunity for patient investors.

Continue Reading At Dividend Sensei



Comments are closed.